Pilot study of a novel computerized task to assess spatial learning in children and adolescents with neurofibromatosis type i

Journal of Child Neurology

Volumn 25, Issue 10, 2010, Pages 1195-1202

  Ullrich, Nicole J ^a   Ayr, Lauren ^a   Leaffer, Emily ^a   Irons, Mira B ^a   Rey Casserly, Celiane ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

arena maze; computerized task; neurofibromatosis type 1; spatial learning

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; COMPUTER AIDED DESIGN; FEMALE; HUMAN; LEARNING; MALE; NEUROFIBROMATOSIS; PRIORITY JOURNAL; PSYCHOMETRY; SCHOOL CHILD; SPATIAL LEARNING; TASK PERFORMANCE; VIRTUAL REALITY MODELING LANGUAGE;

ADOLESCENT; CHILD; DIAGNOSIS, COMPUTER-ASSISTED; DISABILITY EVALUATION; FEMALE; HUMANS; LEARNING DISORDERS; MALE; MEMORY DISORDERS; NEUROFIBROMATOSIS 1; PILOT PROJECTS; USER-COMPUTER INTERFACE;

EID: 77957990320     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073809358454     Document Type: Article

References (38)

1. National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987. Neurofibromatosis. 1988; 1: 172-178.
2. Listernick R., Charrow J. Neurofibromatosis type 1 in childhood. J Pediatr. 1990; 116: 845-853.
3. Cutting LE, Koth CW, Denckla MB How children with neurofibromatosis type 1 differ from "typical" learning disabled clinic attenders: nonverbal learning disabilities revisited. Dev Neuropsychol. 2000; 17: 29-47.
4. Hyman SL, Shores A., North KN The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology. 2005; 65: 1037-1044.
5. Hofman KJ, Harris EL, Bryan RN, Denckla MB Neurofibromatosis type 1: the cognitive phenotype. J Pediatr. 1994; 124: S1 - S8.
6. Coude FX, Mignot C., Lyonnet S., Munnich A. Academic impairment is the most frequent complication of neurofibromatosis type-1 (NF1) in children. Behav Genet. 2006; 11: 1-5.
7. Schrimsher GW, Billingsley RL, Slopis JM, Moore BD III. Visual-spatial performance deficits in children with neurofibromatosis type-1. Am J Med Genet A. 2003; 120: 326-330.
8. Li C., Cheng Y., Gutmann DA, Mangoura D. Differential localization of the neurofibromatosis 1 (NF1) gene product, neurofibromin, with the F-actin or microtubule cytoskeleton during differentiation of telencephalic neurons. Brain Res Dev Brain Res. 2001; 130: 231-248.
9. Shen MH, Harper PS, Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet. 1996; 33: 2-17.
10. Weiss B., Bollag G., Shannon K. Hyperactive Ras as a therapeutic target in neurofibromatosis type 1. Am J Med Genet. 1999; 89: 14-22.
11. Costa RM, Silva AJ Molecular and cellular mechanisms underlying the cognitive deficits associated with neurofibromatosis 1. J Child Neurol. 2002; 17: 622-626; discussion 627-629, 646-651.
12. Costa RM, Federov NB, Kogan JH, et al. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature. 2002; 415: 526-530.
13. Li W., Cui Y., Kushner SA, et al. The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol. 2005; 15: 1961-1967.
14. Kallai J., Makany T., Karadi K., Jacobs WJ Spatial orientation strategies in Morris-type virtual water task for humans. Behav Brain Res. 2005; 159: 187-196.
15. Thomas KG, Hsu M., Laurance HE, Nadel L., Jacobs WJ Place learning in virtual space: III. Investigation of spatial navigation training procedures and their application to fMRI and clinical neuropsychology. Behav Res Methods Instrum Comput. 2001; 33: 21-37.
16. Astur RS, Taylor LB, Mamelak AN, Philpott L., Sutherland RJ Humans with hippocampus damage display severe spatial memory impairments in a virtual Morris water task. Behav Brain Res. 2002; 132: 77-84.
17. Skelton RW, Bukach CM, Laurance HE, Thomas KG, Jacobs JW Humans with traumatic brain injuries show place-learning deficits in computer-generated virtual space. J Clin Exp Neuropsychol. 2000; 22: 157-175.
18. Laurance HE, Learmonth AE, Nadel L., Jacobs WJ Maturation of spatial navigation: convergent findings from computerized spatial environments and self-report. J Cogn Dev. 2003; 4: 211-238.
19. Paquier PF, van Mourik M., Van Dongen HR, Catsman-Berrevoets CE, Creten WL, Stronks DL Clinical utility of the judgment of line orientation test and facial recognition test in children with acquired unilateral cerebral lesions. J Child Neurol. 1999; 14: 243-248.
20. Woodard JL, Benedict RH, Salthouse TA, Toth JP, Zgaljardic DJ, Hancock HE Normative data for equivalent, parallel forms of the Judgment of Line Orientation Test. J Clin Exp Neuropsychol. 1998; 20: 457-462.
21. De Luca CR, Wood SJ, Anderson V., et al. Normative data from the CANTAB. I: development of executive function over the lifespan. J Clin Exp Neuropsychol. 2003; 25: 242-254.
22. Clark CR, Paul RH, Williams LM, et al. Standardized assessment of cognitive functioning during development and aging using an automated touchscreen battery. Arch Clin Neuropsychol. 2006; 21: 449-467.
23. Mayes SD, Calhoun SL WISC-IV and WISC-III profiles in children with ADHD. J Atten Disord. 2006; 9: 486-493.
24. Needelman H., Schnoes CJ, Ellis CR The New WISC-IV. J Dev Behav Pediatr. 2006; 27: 127-128.
25. Beebe DW, Ris MD, Dietrich KN The relationship between CVLT-C process scores and measures of executive functioning: lack of support among community-dwelling adolescents. J Clin Exp Neuropsychol. 2000; 22: 779-792.
26. McCandless S., O'Laughlin L. The clinical utility of the Behavior Rating Inventory of Executive Function (BRIEF) in the diagnosis of ADHD. J Atten Disord. 2007; 10: 381-389.
27. Gioia GA, Isquith PK Ecological assessment of executive function in traumatic brain injury. Dev Neuropsychol. 2004; 25: 135-158.
28. Cohen ML, Kelly PC, Atkinson AW Parent, teacher, child: a trilateral approach to attention deficit disorder. Am J Dis Child. 1989; 143: 1229-1233.
29. Wechsler D. Wechsler Intelligence Scale for Children. 4 th ed. San Antonio, TX: Harcourt Brace Jovanovich; 2003.
30. North K., Joy P., Yuille D., Cocks N., Hutchins P. Cognitive function and academic performance in children with neurofibromatosis type 1. Dev Med Child Neurol. 1995; 37: 427-436.
31. Hyman SL, Arthur Shores E., North KN Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Dev Med Child Neurol. 2006; 48: 973-977.
32. Koth CW, Cutting LE, Denckla MB The association of neurofibromatosis type 1 and attention deficit hyperactivity disorder. Child Neuropsychol. 2000; 6: 185-194.
33. Moore BD III, Ater JL, Needle MN, Slopis J., Copeland DR Neuropsychological profile of children with neurofibromatosis, brain tumor, or both. J Child Neurol. 1994; 9: 368-377.
34. North K. Neurofibromatosis type 1: review of the first 200 patients in an Australian clinic. J Child Neurol. 1993; 8: 395-402.
35. North K., Joy P., Yuille D., et al. Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities. Neurology. 1994; 44: 878-883.
36. Eliason MJ Neurofibromatosis: implications for learning and behavior. J Dev Behav Pediatr. 1986; 7: 175-179.
37. Joy P., Roberts C., North K., de Silva M. Neuropsychological function and MRI abnormalities in neurofibromatosis type 1. Dev Med Child Neurol. 1995; 37: 906-914.
38. Rizzo AA, Cohen I., Weiss PL, et al. Design and development of virtual reality based perceptual-motor rehabilitation scenarios. Conf Proc IEEE Eng Med Biol Soc. 2004; 7: 4852-4855.